BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26079660)

  • 1. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
    Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
    Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
    Lin Q; Song Y; Zhu X; Yang S; Zheng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
    Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
    J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N
    Front Immunol; 2020; 11():976. PubMed ID: 32547545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
    Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells.
    Fluhr H; Seitz T; Zygmunt M
    Breast Cancer Res Treat; 2013 Jan; 137(1):109-18. PubMed ID: 23160925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
    Cox JH; Dean RA; Roberts CR; Overall CM
    J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of chemokine CXC receptor 3, 4 and their ligands at the early pregnancy decidua and villi].
    Bai XX; Kong BH; Zhang YZ; Qu X; Wang HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):904-8. PubMed ID: 19134328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease.
    Marshall A; Celentano A; Cirillo N; McCullough M; Porter S
    PLoS One; 2017; 12(3):e0172821. PubMed ID: 28253295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
    Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
    Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells].
    Song Y; Lin Q; Zheng J; Zhu X; Yang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):673-6. PubMed ID: 25001926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
    Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
    BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
    Zhou H; Wu J; Wang T; Zhang X; Liu D
    Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.